BSX FY 2017 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

FY 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$9.0B+7.9% YoY

Gross Profit

$5.9B64.9% margin

Operating Income

$1.5B16.9% margin

Net Income

$104M1.1% margin

EPS (Diluted)

$0.07

Cash Flow

Operating Cash Flow

$1.4B

Free Cash Flow

$1.1B

Stock-Based Comp.

$127M

Balance Sheet

Total Assets

$19.0B

Total Liabilities

$12.0B

Stockholders' Equity

$7.0B

Cash & Equivalents

$188M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9.0B	$8.4B	+7.9%
Gross Profit	$5.9B	$5.3B	+9.9%
Operating Income	$1.5B	$1.2B	+23.4%
Net Income	$104M	$347M	-70.0%